CARE1 Pragmatic Clinical Trial is an academic phase III study designed to define the optimal combination for patients with kidney cancer.
Europe
Joined October 2023
- Tweets91
- Following12
- Followers35
- Likes4
CARE1 Project retweeted
We are supporting the @IKCCorg World Kidney Cancer Day, please save the date.
This year the theme is ‘Show your kidneys some love'
To find out how you can get involved please follow the link below:
actionkidneycancer.org/get-i…
#kidneycancer #bypatientsforpatients #StrongerTogether
CARE1 Project retweeted
Thanks for highlighting @CARE1Project - up and running in >30 sites in 🇫🇷 🇨🇿 & currently being activated across EU countries 🇳🇱 🇦🇹 soon in 🇬🇧 🇮🇹 🇩🇪 🇬🇷 🇧🇪 🇵🇹 🇫🇮
Special thanks @tompowles1 @ViktorGruenwald @crisuarez08 @g_develasco @IKCCorg @GustaveRoussy @AssoARTuR and all!
CARE1 Project retweeted
We’re looking forward to the IKCC Global Kidney Cancer Summit! Learn more about the event that starts tomorrow: ikcc.org/ikcc-news-notes/ikc… #IKCC25
CARE1 Project retweeted
Please join @AlbigesL @g_develasco #JensBedkeMD & myself at #ESMO24 for a discussion of #kidneycancer that will span topics of #adjuvant & #metastatic dz tx. We have worked hard to incorporate discussion around data presented just a day earlier- incl perspectives on #TiNivo2, #SUNNIFORECAST, #LITESPARK005, as well as updates on #CM9ER, #CLEAR, #KN426 & other studies! See you Saturday evening at 6:30 pm!
CARE1 Project retweeted
Proud and honored to be part of the important @CARE1Project. Grateful for the opportunity to contribute to this groundbreaking project. Huge thanks to @AlbigesL for this terrific opportunity! #CARE1Trial @GustaveRoussy #ESMO24
CARE1 Project retweeted
Annual meeting of the CARE 1 metastatic 1st line RCC study which is open in France 🇫🇷 and will open in 🇬🇧 soon. Biomarker driven trial (PD-L1) of ipi/nivo vs VEGF/PD1 @AlbigesL . The Barts team in Paris enjoying the sunshine !!
CARE1 Project retweeted
@CARE1Project annual meeting randomised frontline #pragmatic #clinicaltrials @GustaveRoussy
Thanks to all investigators and to our ScientificAdvisoryBoard @TurajlicLab @katy_beckermann & PatientAdvisoryBoard @IKCCorg @AssoARTuR @kidneycanceruk
